GUARD — Guard Therapeutics International AB (publ) Cashflow Statement
0.000.00%
- SEK29.75m
- -SEK20.08m
Annual cashflow statement for Guard Therapeutics International AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -81.9 | -115 | -115 | -99.9 | -107 |
| Non-Cash Items | 0.52 | 0.67 | 2.83 | 2.82 | 7.68 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.79 | 12.1 | -3.81 | 2.33 | -9.83 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -77.6 | -102 | -116 | -94.8 | -109 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | — | — | — | — | 0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 176 | 113 | -0.779 | 62.7 | 107 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 98.6 | 12.4 | -117 | -29.6 | -4.36 |